• Join
  • Login
  • Contact

Search abstracts

Acting in public health intrerest: GPOs (Government pharmaceutical organisations)

  • In: A4 - Do patents limit access to new medicines? on Tuesday, 2 September 2014, 12:15-13:45
  • At: Bangkok (Thailand) (2014)
  • Type: Presentation
  • By: WIBULPOLPRASERT, Suwit (International Health Policy Program, Ministry of Public Health, Nonthaburi, Thailand)
  • Abstract:

    The patent system was established to incentivize the inventors of new technologies to reveal the secret of their inventions in exchange for the market monopolization. This is to compensate for the cost of invention. It was expected that the IP systems would stimulate more inventions to get better technologies to benefit the health of the people.


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses